The human clinical phenotypes of altered CHRNA7 copy number
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 97 (4) , 352-362
Abstract
No abstract availableKeywords
Funding Information
- Doris Duke Charitable Foundation (#2011034)
This publication has 78 references indexed in Scilit:
- De novo 15q13.3 microdeletion with cryptogenic west syndromeAmerican Journal of Medical Genetics Part A, 2013
- De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophreniaMolecular Psychiatry, 2011
- Pharmacotherapeutic Implications of the Association Between Genomic Instability at Chromosome 15q13.3 and Autism Spectrum DisordersClinical Neuropharmacology, 2011
- Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblingsEuropean Journal of Medical Genetics, 2011
- Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypesEuropean Journal of Human Genetics, 2011
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to FunctionPhysiological Reviews, 2009
- Large recurrent microdeletions associated with schizophreniaNature, 2008
- Rare chromosomal deletions and duplications increase risk of schizophreniaNature, 2008
- Discovery of previously unidentified genomic disorders from the duplication architecture of the human genomeNature Genetics, 2006
- Association of Promoter Variants in the α7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in SchizophreniaArchives of General Psychiatry, 2002